OBJECTIVE -To assess changes in the quality of care in Norway for patients with type 2 diabetes. RESULTS -Between 1995 and 2005, there were significant improvements in the proportion of patients for whom important laboratory analyses, smoking habits, height, weight, and referral to eye examination were recorded. Mean A1C declined from 7.74 to 7.15%, systolic blood pressure from 150.0 to 140.4 mmHg, and cholesterol from 6.28 to 5.0 mmol/l (P Ͻ 0.001, age and sex adjusted). The 10-year risk of coronary heart disease for an average male patient declined from 42 to 29%.
I
mproving the quality of diabetes care has been a major focus of the Norwegian College of General Practice since the first diabetes guidelines for general practice were published in 1988. Guidelines were revised in 1995, 2000, and the late autumn of 2005 (1) . Guideline targets for A1C Յ7.5% and serum cholesterol Յ5.0 mmol/l remained unchanged from 1995 to 2005, whereas target blood pressure was lowered from Յ140/90 to Յ140/85 mmHg in 2000. Our objective in this study was to assess changes in the quality of type 2 diabetes care in general practice from 1995 to 2005.
RESEARCH DESIGN AND METHODS -Quality of diabetes care
was assessed in a cross-sectional survey of 33 practices in 1995 (2) . All practices (n ϭ 35) with electronic medical records in two representative areas of Norway were selected to take part in the first survey. The same 33 practices agreed to participate in the survey of 2005.
All patients with type 2 diabetes in 1995 (n ϭ 1,667) and 2005 (n ϭ 3,013) were identified using electronic search programs with manual verification. Patients in nursing homes, patients receiving diabetes care from specialists, and patients with less than 6 months of follow-up were excluded, leaving 1,470 subjects (49.5% of whom were male) in 1995 and 2,699 (51.2% male) in 2005 for analysis. Variables included demographic data, processes of care, outcomes of care, and medications. The most recent result was recorded if more than one value was available. Variables had identical definitions in both surveys.
Statistical tests were performed using SPSS version 13. Differences between means in Table 1 were tested using an ANOVA analysis adjusted for age and sex. Other results were adjusted for clustering by using practice-specific proportions or means as observations in Student's t test. The UK Prospective Diabetes Study riskengine model (3) was used to calculate the 10-year risk reduction for coronary disease.
RESULTS -The majority of patients were Caucasian (98%). Between 1995 and 2005, mean age decreased (69.1 to 66.3 years; P Ͻ 0.001), mean diabetes duration increased (6.6 to 7.0 years; P ϭ 0.047), and mean weight increased (81.1 to 86.1 kg; P Ͻ 0.001), whereas mean height was comparable between both surveys. The proportion of patients for whom important processes of care had been recorded improved as follows: cholesterol 46 to 88% (difference [⌬] 42% [95% CI 35-48]; P Ͻ 0.001), HDL cholesterol 18 to 61% (⌬43% [36 -49]; P Ͻ 0.001), microalbumin 13 to 33% (⌬20% [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] ; P Ͻ 0.001), smoking habits 13 to 57% (⌬44% [39 -50]; P Ͻ 0.001), height 13 to 39% (⌬26% [16 -36]; P Ͻ 0.001), weight 38 to 56% (⌬18% [8 -28] ; P ϭ 0.001), and referral to eye examination 30 to 74% (⌬44% [37-50]; P Ͻ 0.001). A1C and blood pressure were recorded for approximately 90% of subjects in both surveys. Table 1 shows mean values for risk factors related to treatment groups and the proportion of patients achieving national targets. Treatment was more intensive in 2005 compared with 1995.
Among patients using antihyperglycemic therapy, 23 vs. 12% (⌬11% [95% CI 7-16]; P Ͻ 0.001) received two or more oral hypoglycemic agents and 13 vs. 1% (⌬12% [9 -14] ; P Ͻ 0.001) received both oral hypoglycemic agents and insulin. Few patients used glitazones (2%) or acarbose (1%) in 2005. Of patients using antihyperglycemic therapy, the percent of patients with A1C Ͻ6.5% increased from 10 to 22% (⌬12% [7- (Table 1 ). There were no clinically important sex differences in the improvement of risk factor control or treatment.
Coronary risk reduction was calculated for an average patient (age 67 years, nonsmoking, with 7 years' diabetes duration) using mean values for major risk factors in 1995 and 2005. The absolute 10-year risk reductions were from 42 to 28% for men and from 39 to 27% for women.
CONCLUSIONS -Risk factor control has improved considerably. Between 1995 and 2005, reductions in mean values for A1C, blood pressure, and cholesterol were 0.6%, 10/4 mmHg, and 1.3 mmol/l, respectively, despite weight gain. This could be explained by more intensive treatment due to increased impact of guidelines after the publication of the UK Prospective Diabetes Study results, changes in diagnostic criteria, increased efforts to diagnose diabetes earlier, or a trend toward healthier living because blood pressure and cholesterol have decreased in the general population of Norway (4). Some of these factors together with an increase in the prevalence of diabetes due to obesity may explain the marked increase in the number of patients with type 2 diabetes attending the practices. Very similar reductions in A1C and blood pressure among patients with type 2 diabetes in general practice have been reported by the Swedish National Diabetes Register between 1996 and 2005 (5). A decline in A1C from 7.8 to 7.2% between 1999 and 2004 among adult patients with diabetes in the U.S. has been reported in an analysis of National Health and Nutrition Examination Survey data (6) . Other studies (5-10) that have performed the latest survey since 2002 report improvements in risk factor control, whereas studies reporting in 2002 or earlier (11) (12) (13) (14) find little or no improvement.
Improvements in risk factor control, processes of care, and the more widespread use of metformin suggest that practitioners are responding to guidelines. Apart from educational meetings, there are no additional incentives for practitioners to follow national guidelines. An independent study has confirmed that the guidelines are used by 52% of general practitioners (15) .
Our findings are probably represen- Data are % (n), means Ϯ SD, or differences (95% CI) unless otherwise indicated. *P values for differences in means of outcome measures are derived from an ageand sex-adjusted ANOVA analysis. P values for differences in percentage achieving national targets are adjusted for clustering by using practice-specific means as proportions in a paired t test. BP, blood pressure; DBP, diastolic blood pressure; SBP, systolic blood pressure. 
